FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2530099367> ?p ?o ?g. }

• W2530099367 abstract "Abstract Approximately 25–30 % of children newly diagnosed with acute lymphoblastic leukemia (ALL) will eventually experience leukemic relapse. Bone marrow is the most common site of recurrence. Usually achieving a durable second remission is complicated by toxicity and resistance of the disease. Here we documented our patients in order to see the prognosis of relapsed pediatric ALL cases. RESULTS. From August 1990 to August 2005 children diagnosed with ALL and treated with BFM based protocols in Cerrahpasa Medical Faculty Pediatric Hematology-Oncology Department were enrolled to this study. There were 225 children aged median 6 years( 3 months–18 years) (136 boys/89 girls), 28 % SR, 50 % MR, 22 % HR. The whole group EFS is 72,6 % and RFI 81,8 %. Twenty-nine (12,8 %) patients were relapsed. Bone marrow recurrences were isolated in 19 patients, and combined with an extramedullary site in 8 patients (4 CNS, 2 testis, 1 retinal,1 dermal). Only two patients had isolated extramedullary site (testis) relapse. The median time to recurrence was 23 months (range 4–128 months). Five patients refused a secondary treatment. Of 24 chemotherapy given patients, 6 patients were lost just after induction therapy due to toxicity before a reliable remission evaluation was done. In three early relapses a second remission could not be attained. Twenty-one patients (72.4 %) achieved a second remission (median length, 4 months; range, 1–114 months)( mean16 ± 80 months). The 5-year survival probability among all patients was 27.2 % ± 8.2 %. Of 8 surviving patients, 3 are in remission more than 5 years, 3 are in remission 2–5 years of period and only 2 less than 1 year. One patient who relapsed for second time is in 3th remission for 65 months period. Bone marrow transplantation was the done for only 3 patients, one is very newly done, the other two relapsed after engrafmant and were lost. CONCLUSIONS. Despite acceptable long-term second EFS rates for a minor group of patients, childhood ALL recurrences signal a poor outcome being the problem of childhood ALL therapy." @default.
• W2530099367 created "2016-10-21" @default.
• W2530099367 creator A5002176677 @default.
• W2530099367 creator A5051276644 @default.
• W2530099367 creator A5066380317 @default.
• W2530099367 creator A5072133312 @default.
• W2530099367 creator A5074027924 @default.
• W2530099367 creator A5090715353 @default.
• W2530099367 date "2005-11-16" @default.
• W2530099367 modified "2023-10-16" @default.
• W2530099367 title "Outcome after Relapse in Childhood Acute Lymphoblastic Leukaemia - Results of a Single Center for a Period of 15 Years." @default.
• W2530099367 doi "https://doi.org/10.1182/blood.v106.11.4582.4582" @default.
• W2530099367 hasPublicationYear "2005" @default.
• W2530099367 type Work @default.
• W2530099367 sameAs 2530099367 @default.
• W2530099367 citedByCount "0" @default.
• W2530099367 crossrefType "journal-article" @default.
• W2530099367 hasAuthorship W2530099367A5002176677 @default.
• W2530099367 hasAuthorship W2530099367A5051276644 @default.
• W2530099367 hasAuthorship W2530099367A5066380317 @default.
• W2530099367 hasAuthorship W2530099367A5072133312 @default.
• W2530099367 hasAuthorship W2530099367A5074027924 @default.
• W2530099367 hasAuthorship W2530099367A5090715353 @default.
• W2530099367 hasConcept C126322002 @default.
• W2530099367 hasConcept C141071460 @default.
• W2530099367 hasConcept C187212893 @default.
• W2530099367 hasConcept C194409129 @default.
• W2530099367 hasConcept C2776694085 @default.
• W2530099367 hasConcept C2778461978 @default.
• W2530099367 hasConcept C2779709957 @default.
• W2530099367 hasConcept C2780007613 @default.
• W2530099367 hasConcept C2781107101 @default.
• W2530099367 hasConcept C2909962599 @default.
• W2530099367 hasConcept C3018657049 @default.
• W2530099367 hasConcept C71924100 @default.
• W2530099367 hasConceptScore W2530099367C126322002 @default.
• W2530099367 hasConceptScore W2530099367C141071460 @default.
• W2530099367 hasConceptScore W2530099367C187212893 @default.
• W2530099367 hasConceptScore W2530099367C194409129 @default.
• W2530099367 hasConceptScore W2530099367C2776694085 @default.
• W2530099367 hasConceptScore W2530099367C2778461978 @default.
• W2530099367 hasConceptScore W2530099367C2779709957 @default.
• W2530099367 hasConceptScore W2530099367C2780007613 @default.
• W2530099367 hasConceptScore W2530099367C2781107101 @default.
• W2530099367 hasConceptScore W2530099367C2909962599 @default.
• W2530099367 hasConceptScore W2530099367C3018657049 @default.
• W2530099367 hasConceptScore W2530099367C71924100 @default.
• W2530099367 hasLocation W25300993671 @default.
• W2530099367 hasOpenAccess W2530099367 @default.
• W2530099367 hasPrimaryLocation W25300993671 @default.
• W2530099367 hasRelatedWork W1966080082 @default.
• W2530099367 hasRelatedWork W1977938535 @default.
• W2530099367 hasRelatedWork W2042226495 @default.
• W2530099367 hasRelatedWork W2051266410 @default.
• W2530099367 hasRelatedWork W2052283488 @default.
• W2530099367 hasRelatedWork W2064930805 @default.
• W2530099367 hasRelatedWork W2091794116 @default.
• W2530099367 hasRelatedWork W2405390835 @default.
• W2530099367 hasRelatedWork W2426236262 @default.
• W2530099367 hasRelatedWork W2596964968 @default.
• W2530099367 isParatext "false" @default.
• W2530099367 isRetracted "false" @default.
• W2530099367 magId "2530099367" @default.
• W2530099367 workType "article" @default.